Valvular & structural heart disease

Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with transcatheter aortic valve replacement (TAVR)

Eur Heart J Cardiovasc ImagingPublished Cohort study

Authors' conclusion

Baseline flow status was not an independent predictor of mid-term mortality among all-comers with severe AS undergoing TAVR. Flow recovery early after TAVR was frequent. Post-TAVR FR, but not SVi, was independently associated with mid-term all-cause mortality.

Study context

Population
Patients with severe aortic stenosis (AS) undergoing TAVR731 with post-TAVR assessment
Participants
980 patients
Exposure
Low vs normal flow before and after TAVR
Outcome
All-cause mortality
Follow-up
Up to 3 years

Main finding

As reported in the abstract

All-cause mortality up to 3 years (multivariable Cox)
Hazard ratio (95% CI)
SVibaseline flow status (SVi <35 mL/m²); not an independent predictor
1.22(0.85–1.82)
FRbaseline flow status (FR <200 mL/s); not an independent predictor
0.78(0.48–1.27)
Reduced FR following TAVRpost-TAVR; independent predictor
1.67(1.02–2.74)
SVipost-TAVR; not an independent predictor
0.97(0.53–1.78)

Observational data: associations, not effects.

Further findings

OutcomeReduced FRP value
3-year estimated mortality by FR trajectory · up to 3 yearsRecovered FR vs Reduced FR37.7%P = 0.003
3-year estimated mortality by FR trajectory · up to 3 yearsRecovered FR vs Normal baseline FR · similarP = 0.317
  • 3-year estimated mortality by flow rate (FR) trajectory: Recovered FR 13.3%

Flow recovery after TAVR (baseline low flow) · early (5 days, IQR 2-29) post-TAVR

Stroke volume index (SVi) recovered
40.1%
FR recovered
49.0%

Original publication

Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR. Eur Heart J Cardiovasc Imaging. Published 8 February 2023. doi:10.1093/ehjci/jead018

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.